SCHEMBL44299

SCHEMBL44299

O=C(CO)[C@H](O)[C@H](O)CO

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
PDE4A P27815 1/20 0.44
LMNA P02545 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.38
USP2 O75604 1/20 0.36
SLCO1B1 Q9Y6L6 1/20 0.36
OR51E2 Q9H255 1/20 0.35
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37387 1.00 CYP2C9 (0.50) CYP2C9TSHRPDE4ALMNAL3MBTL1
SCHEMBL299290 1.00 CYP2C9 (0.50) CYP2C9TSHRPDE4ALMNAL3MBTL1
SCHEMBL2961724 1.00 CYP2C9 (0.50) CYP2C9TSHRPDE4ALMNAL3MBTL1
SCHEMBL3649734 1.00 CYP2C9 (0.50) CYP2C9TSHRPDE4ALMNAL3MBTL1
SCHEMBL37388 1.00 CYP2C9 (0.50) CYP2C9TSHRPDE4ALMNAL3MBTL1
SCHEMBL23723109 1.00 CYP2C9 (0.50) CYP2C9TSHRPDE4ALMNAL3MBTL1
SCHEMBL31338625 1.00 CYP2C9 (0.50) CYP2C9TSHRPDE4ALMNAL3MBTL1
Water SCHEMBL4393893 0.97 CYP2C9 (0.48) CYP2C9TSHRPDE4ALMNAL3MBTL1
SCHEMBL30504628 0.97 CYP2C9 (0.48) CYP2C9TSHRPDE4ALMNAL3MBTL1
SCHEMBL29825289 0.97 CYP2C9 (0.48) CYP2C9TSHRPDE4ALMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 29426 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122081190-A Recombinant halomonas utilization of CO2And acetic acid as substrate for producing melanin 2026-05-26 CN claimed
WO-2026107335-A1 COMPOSITIONS AND METHODS FOR TREATING HEPATIC DISEASES BY INHIBITING EFHD1 UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2026-05-21 WO claimed
US-20260137806-A1 INTERCALATING SUGAR MOLECULES XALUD THERAPEUTICS, INC. (US) 2026-05-21 US claimed
EP-4182375-B1 RELEASABLE COMPOSITIONS BASED ON POLYACETALS DELO INDUSTRIE KLEBSTOFFE GMBH & CO KGAA (DE) 2026-05-20 EP claimed
CN-122055374-A Lipid compounds and compositions for tissue-specific delivery of active substances 韩国生命工学研究院 2026-05-15 CN claimed
WO-2026101930-A1 PHOSPHOGLYCOLIPIDS AND THEIR DERIVATIVES GlycoSurf, Inc. (US) 2026-05-15 WO claimed
US-20260130404-A1 SWEETNESS AND TASTE IMPROVEMENT OF NON-SUCROSE SWEETENERS WITH D-SUGARS OR L-SUGARS THE COCA COLA CO (US) 2026-05-14 US claimed
EP-3869192-B1 METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE HUMAN METABOLOMICS INST INC (CN) 2026-05-13 EP claimed
US-12622889-B2 S-β-hydroxybutyrate esters for improving metabolic function AXCESS GLOBAL SCIENCES, LLC (US) 2026-05-12 US claimed
EP-4731644-A1 GLYCATED PROTEINS Pnuvax, Inc. (CA) 2026-04-29 EP claimed
EP-0206460-A2 L-phenylalanine dehydrogenase and use thereof SAGAMI CHEMICAL RESEARCH CENTER (JP) 1986-12-30 EP claimed
EP-0189707-A2 Recombinant DNA which can be introduced into plant cells PLANT GENETIC SYSTEMS N.V. (BE) 1986-08-06 EP claimed
EP-0189427-A1 ORALLY ACTIVE HEPARIN MULTIPLETS. BODOR NICHOLAS S 1986-08-06 EP claimed
WO-1985005362-A1 ORALLY ACTIVE HEPARIN MULTIPLETS BODOR NICHOLAS S 1985-12-05 WO claimed
EP-0133795-A1 Gaba esters and gaba analogue esters THE McLEAN HOSPITAL CORPORATION (US) 1985-03-06 EP claimed
WO-1985000520-A1 GABA ESTERS AND GABA ANALOGUE ESTERS THE MCLEAN HOSPITAL CORPORATION (US) 1985-02-14 WO claimed
US-4460767-A COPPER COMPOUND, CHLORIDE OR BROMIDE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1984-07-17 US claimed
US-4418058-A ANTIBACTERIAL AGENTS SHIONOGI & CO., LTD. (JP) 1983-11-29 US claimed
US-3970522-A CULTIVATION OF BACILLUS TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-07-20 US claimed
US-3948883-A Synthesis of purine nucleosides THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1976-04-06 US claimed